Covid vaccination: Walk-ins allowed for 18-44 age bracket at govt centres

Private centres have to continue publishing their vaccination schedule in advance for online appo­in­tments

Vaccines
A press state­ment said one of the reas­o­ns to bring in this feature was that those wit­h­out access to internet or sm­a­rtphones may have limi­ted access to vaccin­ation | Photo: Bloomberg
Ruchika Chitravanshi New Delhi
1 min read Last Updated : May 25 2021 | 12:09 AM IST
The government has allowed walk-ins through on-site registration and appoint­ments for vaccina­tion of the 18-44 age group, on CoWIN. This feature has been enabled only for government vaccination centres. 

Private centres have to continue publishing their vaccination schedule in advance for online appo­in­tments. So far, only those with prior appoin­tments were allowed to get the jab, in the 18-44 age group. In case of sessions exclusively organised with online slots, some doses may still be left unutilised towards the end of the day. The government said that in such cases, on-site registration of a few ben­eficiaries may be nece­ssary to minimise wastage. 


A press state­ment said one of the reas­o­ns to bring in this feature was that those wit­h­out access to internet or sm­a­rtphones may have limi­ted access to vaccin­ation. 


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineVaccinationVaccine

Next Story